Centre Hospitalier De Dreux
- Address
- 44 Avenue Du Pdt J Fitzgerald Kennedy, 28100 Dreux, France
Bacterial Infections and Mycoses
The Centre Hospitalier De Dreux is evaluating a novel inhaled antibiotic approach for patients with ventilator-associated tracheobronchitis, aiming to lower the chance of progressing to pneumonia during intensive care.
- Inhaled amikacin therapy
- Placebo‑controlled efficacy assessment
- Prevention of ventilator‑associated pneumonia
- Critical care patient outcomes
This trial highlights the site’s commitment to improving infection control strategies in the ICU setting.
Cardiovascular Diseases
Researchers at the Dreux hospital are testing whether adding acetazolamide to standard heart‑failure therapy can enhance decongestion and reduce patient weight, with monitoring supported by remote monitoring technologies.
- Diuretic combination strategies
- Weight reduction in heart failure
- Symptom relief and quality of life
- Ambulatory heart‑failure management
The study reflects the center’s focus on advancing outpatient care for chronic cardiac conditions.
Respiratory Tract Diseases
At Centre Hospitalier De Dreux, a double‑blind trial investigates the impact of a short course of inhaled therapy on the progression of respiratory infections in ventilated patients, seeking to improve outcomes for those with ventilator‑associated tracheobronchitis.
- Respiratory infection prevention
- ICU ventilation complications
- Short‑duration antibiotic regimens
- Clinical safety and efficacy
Findings from this research could shape future guidelines for managing critical‑care respiratory disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier De Dreux
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A multicentre, double-blind, randomized controlled trial of inhaled amikacin versus placebo in critically ill patients with ventilator-associated tracheobronchitis (AMIVAT) | Centre Hospitalier Regional Universitaire De Tours | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetazolamide | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.